Author:
Guerrero R.,Schmidt-Richberg A.,Ledig C.,Tong T.,Wolz R.,Rueckert D.
Funder
Innovate UK
Alzheimer's Disease Neuroimaging Initiative (ADNI)
DOD ADNI
National Institute on Aging
National Institute of Biomedical Imaging and Bioengineering
AbbVie
Alzheimer’s Association
Alzheimer’s Drug Discovery Foundation
Araclon Biotech
BioClinica, Inc.
Biogen
Bristol-Myers Squibb Company
CereSpir, Inc.
Cogstate
Eisai Inc.
Elan Pharmaceuticals, Inc.
Eli Lilly and Company
EuroImmun
F. Hoffmann-La Roche Ltd
Genentech, Inc.
Fujirebio
GE Healthcare
IXICO Ltd.
Janssen Alzheimer Immunotherapy Research & Development, LLC.
Johnson & Johnson Pharmaceutical Research & Development LLC.
Lumosity
Lundbeck
Merck & Co., Inc.
Meso Scale Diagnostics, LLC.
NeuroRx Research
Neurotrack Technologies
Novartis Pharmaceuticals Corporation
Pfizer Inc.
Piramal Imaging
Servier
Takeda Pharmaceutical Company
Transition Therapeutics
Canadian Institutes of Health Research
Northern California Institute for Research and Education
Subject
Cognitive Neuroscience,Neurology
Reference53 articles.
1. Predicting the rate of cognitive decline in aging and early Alzheimer disease;Adak;Neurology,2004
2. Modeling the time-course of Alzheimer dementia;Ashford;Curr. Psychiatry Rep.,2001
3. Laplacian Eigenmaps and spectral techniques for embedding and clustering;Belkin,2002
4. Statistical analysis of longitudinal neuroimage data with linear mixed effects models;Bernal-Rusiel;NeuroImage,2012
5. Spatiotemporal linear mixed effects modeling for the mass-univariate analysis of longitudinal neuroimage data;Bernal-Rusiel;NeuroImage,2013
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献